CommercialCoverageMedium impact
Drug Policy Criteria Change
Arkansas Blue Cross Blue Shield·AR · Oncology, Hematology·Pharmacy
Effective date
May 3, 2026
We identified it
Jun 19, 2026
Summary
Arkansas Blue Cross added a new drug Armlupeg (pegfilgrastim-unne) to their formulary program for Standard, Metallic, and Essential plans. This expands the list of approved pegfilgrastim drugs that already includes Neulasta, Fulphila, Fylnetra, Nyvepria, Stimufend, Udenyca, and Ziextenzo.
Action Required
By May 3, 2026: Update billing system and drug formulary references to include Armlupeg (pegfilgrastim-unne) as an approved option for Standard, Metallic, and Essential Arkansas Blue Cross plans. Notify providers that this new pegfilgrastim option is now available and covered under the existing formulary criteria.